RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125

Benzinga · 22h ago
RBC Capital analyst Kendall Au maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $110 to $125.